Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 entities : Igm biosciences, inc. save search
Multimeric IgM Antibodies Targeting DR5 are Potent and Rapid Inducers of Tumor Cell Apoptosis In Vitro and In Vivo
Published: 2021-11-04 (Crawled : 17:00) - igmbio.com
IGMS | $7.705 14.15% 260K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
antibody in vitro
Birinapant clinical study initiated by IGM Biosciences
Published: 2021-11-04 (Crawled : 14:15) - prnewswire.com
IGMS | $7.705 14.15% 260K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
initiated bioscience
Abstract #132: A Phase 1 Dose Escalation Study of IGM-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies
Published: 2021-11-04 (Crawled : 14:00) - igmbio.com
IGMS | $7.705 14.15% 260K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
anti-cd3 phase 1 t-cell
IGM Biosciences Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-04 (Crawled : 14:00) - igmbio.com
IGMS | $7.705 14.15% 260K
|
Health Technology
|
| O: -9.65%
H: 10.43%
C: 8.35%
financial results results bioscience
Gainers vs Losers
| 86% | 14% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
Your saved searches
Save your searches and get alerts when important news are released.